People with ulcerative colitis, a form of IBD, who were taking the new drug Omvoh and achieved clinical remission after 1 ...

A once-daily pill for ulcerative colitis has delivered strong results in a clinical trial, easing symptoms even in patients ...

Crohn's disease and ulcerative colitis. Here's how to tell which one you have.

Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated achieving ...

The latest medical guidelines do not recommend probiotic supplements for ulcerative colitis, due to a lack of evidence.

DEAR DR. ROACH: You recently wrote about colitis, aka inflammation of the colon. Could you please explain how to treat and prevent it? -- M.C. ANSWER: “Colitis” does mean inflammation of the colon, ...

Abivax SA ADR (NASDAQ:ABVX) shares climbed 7.7% in premarket trading Monday after the clinical-stage biotechnology company ...

Once-daily oral obefazimod met the primary endpoint of clinical remission at 8 weeks in a highly refractory population of ...

What Is Infusion for Ulcerative Colitis? If your doctor has recommended infusion therapy, this is probably because standard treatment hasn’t helped relieve symptoms caused by moderate-to-severe ...

Eli Lilly's four-year LUCENT-3 study shows Omvoh maintained high remission rates and a consistent safety profile in ...

The TNF-alpha inhibitor is indicated to treat children weighing at least 15 kg living with moderately to severely active ...

Johnson & Johnson (NYSE: JNJ) today announced additional Week 12 results from the Phase 2b ANTHEM-UC study of icotrokinra, a first-in-class investigational targeted oral peptide that selectively ...